|
| |
Image Results
Loading...
Loading...
Omrix Biopharmaceuticals Manufacturing Location Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Fibrin Sealant (Human) (Crosseal), OMRIX biopharmaceuticals, Ltd.
Utility systems, manufacturing equipment, manufacturing processes and analytical ... Location associated with the Production of Crossealâ„¢. OMRIX ... A pre- license inspection of the facilities of OMRIX biopharmaceuticals involved in the ...
http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBlo...
|
Omrix Biopharmaceuticals, Inc. Announces Positive Phase 3 Clinical ...
16 Oct 2006 ... proprietary protein purification technology and manufacturing know-how. ... Contact: OMRIX Biopharmaceuticals, Inc. Investors: Michael ...
http://www.biospace.com/news_story.aspx?NewsEntityId=33174...
|
Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
24 Nov 2008 ... Omrix's Biopharmaceutical Expertise Complements ETHICON's ... Omrix's Israeli- based manufacturing and research & development expertise will ...
http://www.jnj.com/connect/news/corporate/20081124_060000...
|
Clinical use of topical thrombin as a surgical hemostat
(Omrix Biopharmaceuticals 2007). All stand alone thrombin, regardless of origin, .... Omrix Biopharmaceuticals. Packet Insert for EvithromLast updated 2007. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727895/...
|
Evithrom, Thrombin, Topical (Human)
Virus Inactivation/Removal Studies: The manufacturing process for EVITHROM includes ... are performed at Omrix biopharmaceuticals, Ltd., MDA Blood Bank, ...
http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBlo...
|
Safety of topical thrombins: the ongoing debate
... product (pdThrombin) (Evithrom, OMRIX biopharmaceuticals, Kiryat Ono, Israel ); ... These manufacturing changes were designed to remove immunogenic ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749812/...
|
2003 Biological License Application Approvals
... is ineffective or impractical, 125010/0, OMRIX biopharmaceuticals, Ltd ... Source Plasma, For further manufacturing, 125074/0, DCI Biologicals ...
http://www.fda.gov/BiologicsBloodVaccines/DevelopmentApprova...
|
Executive Board & strategic committee: IPSOGEN
He served as Development and Manufacturing Director of biological agents in the ... Kevin is also a board member at Omrix BioPharmaceuticals, Inc. and VION ...
http://www.ipsogen.com/corporate/people-jobs/executive-board...
|
Article : Life Sciences Strategic Deal-Making Trends Genetic ...
1 Oct 2006 ... 19% and Omrix BioPharmaceuticals(www.omrix.com) was up 26%. ... manufacturing revenues and royalties on worldwide product sales. ...
http://www.genengnews.com/articles/chitem.aspx?aid=1879&chid...
|
2004
3 Sep 2009 ... May 27, 2004, OMRIX biopharmaceuticals, Ltd. Center for Biologics Evaluation and Research, Promotional Claims/Misbranded, N/A * ...
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2...
|
|